Weekly AI/ML & Biotech Digest — Nov 2 to Nov 8, 2026
Although the pandemic of SARS-CoV-2 is over, there are still many cases reported. The recent article by Trull and colleagues in PNAS showed that BA.2.87.1-like variants may escape recognition by the preexisting NTD-targeting antibodies, potentially reducing protection. What is more interesting and alarming is that this study suggests the remaining evolutionary space is big enough for new immune-escape variants. In other words, there is a realistic reason to believe SARS-CoV-2 may still evolve from the ongoing spreads although it seemed less life threatening for now. This is study is the first article listed below. 🧬 Biotech ★ Antigenic landscape of a highly mutated SARS-CoV-2 spike in ongoing viral evolution — Reveals that extensive N-terminal domain remodeling in BA.2.87.1 Spike increases flexibility and interacts with a heme metabolite to expose an immunodominant epitope. (weekly-pnas, 2026-10-28) ★ Soleil Wizman on X: "Clinical Development in an Age of Cheap Molecules...